Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase 1 1

Status

Unknown 7Completed 1

Sponsor Class

OTHER 575INDUSTRY 444NIH 82OTHER_GOV 28NETWORK 23UNKNOWN 8FED 2

Study Type

Interventional 7Observational 1

Sponsor

Cancer Type

Thoracic 8CNS 1

Conditions

Breast Neoplasms 42Esophageal Neoplasms 24Stomach Neoplasms 21Rectal Neoplasms 15Carcinoma, Non-Small-Cell Lung 14Colorectal Neoplasms 12Neoplasms 10Lung Neoplasms 10Brain Neoplasms 10Triple Negative Breast Neoplasms 9Small Cell Lung Carcinoma 8Squamous Cell Carcinoma of Head and Neck 7Neoplasm Metastasis 6Esophageal Squamous Cell Carcinoma 6Nasopharyngeal Carcinoma 5Lymphoma, Large B-Cell, Diffuse 5Carcinoma, Hepatocellular 5Recurrence 4Radiation Injuries 4Melanoma 4Lymphoma, Extranodal NK-T-Cell 4Head and Neck Neoplasms 4Uterine Cervical Neoplasms 3Meningeal Carcinomatosis 3Lymphoma 3Leukemia, Myeloid, Acute 3Hormone Receptor Positive Advanced Breast Cancer 3HER2-positive Breast Cancer 3Colonic Neoplasms 3Vomiting 2

Interventions

apatinib 2Etoposide 2tislelizumab 1camrelizumab 1anlotinib 1Radiotherapy 1Irinotecan 1Immunotherapy 1Drug Therapy 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
UNKNOWN × Small Cell Lung Carcinoma × Clear all
NCT04947774 2021-09-22

Prophylactic Cranial Irradiation in Extensive-stage Small Cell Lung Cancer

ChineseAMS

Unknown
100 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT04500145 2021-02-01

Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung Cancer

ChineseAMS

Phase 3 Unknown
350 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT04683198 2020-12-24

Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC

ChineseAMS

Phase 2 Unknown
69 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT04620837 2020-11-09

Tislelizumab in Combination With Anlotinib With ES-SCLC as Maintenance Therapy After First Line Chemotherapy

ChineseAMS

Phase 2 Unknown
25 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT04535739 2020-09-02

PCI for Patients With ES-SCLC After RCT:a Prospective Randomized Study

ChineseAMS

Phase 3 Unknown
414 enrolled
CNSThoracic

Brain Neoplasms, Small Cell Lung Carcinoma

NCT03971214 2019-06-04

PICARES

ChineseAMS

Phase 1 Unknown
6 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT02995187 2017-09-07

Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)

ChineseAMS

Phase 2 Unknown
25 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT02323737 2014-12-30

Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer

ChineseAMS

Phase 2 Completed
62 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡